Surgical Infections Linked to Drug-Resistant Bacteria
By HospiMedica International staff writers Posted on 01 Mar 2018 |

Image: A hospital ward in Honduras (Photo courtesy of SafeSurgery.com).
A new study suggests that low-income countries carry a disproportionately greater burden of surgical site infection (SSI), and might have higher rates of antibiotic resistance.
Researchers at the University of Edinburgh (United Kingdom), the University of Warwick (Coventry, United Kingdom), and other institutions conducted an prospective, multicenter study of patients undergoing elective or emergency gastrointestinal (GI) resection between Jan 4, 2016, and July 31, 2016, so as to quantify the post-surgical burden of SSI all over of the world. In all, 12,539 patients from 343 hospitals in 66 countries participated in the study. Of these, 58.5% were from high human development index (HDI) countries, 31.2% were from middle HDI countries, and 10.2% of patients were from low-HDI countries.
The results revealed that 12.3% of patients suffered a SSI within 30 days of surgery. The incidence of SSI varied between countries; while those with a high HDI had a 9.4% of incidence of SSI, middle-income countries showed a 14% incidence rate, while those with low income experienced a 23.2% of SSI. The highest SSI incidence in each HDI group was after dirty surgery, with 17.8% in high-HDI countries; 31.4% in middle-HDI countries; and 39.8% in low-HDI countries. Following adjustment, patients in low-HDI countries were at greatest risk of SSI, with 21.6% of SSI patients developing an infection resistant to the prophylactic antibiotic used. The study was published on February 13, 2018, in Lancet Infectious Diseases.
“The incidence of SSI remained higher in low-HDI countries than in middle-HDI or high-HDI countries, despite adjustment for factors describing patients, diseases (including contamination), procedures, safety, and hospitals,” concluded senior author Ewen Harrison, MD, of the University of Edinburgh, and colleagues. “Length of hospital stay was three times longer for patients affected by SSI than for patients with no SSI. Delayed return to work or school carries a societal burden, which is likely to be greater in lower middle income countries.”
SSI is the most common postoperative complication, occurring in approximately 2-5% of patients who undergo clean extra-abdominal surgeries, such as thoracic and orthopedic surgery, and in up to 20% of patients who undergo intra-abdominal surgery interventions. Besides the pain and suffering to patients, it could lead to catastrophic health expenditure and impoverishment to those patients who are required to pay for their own treatment, and a significant financial burden on healthcare providers.
Related Links:
University of Edinburgh
University of Warwick
Researchers at the University of Edinburgh (United Kingdom), the University of Warwick (Coventry, United Kingdom), and other institutions conducted an prospective, multicenter study of patients undergoing elective or emergency gastrointestinal (GI) resection between Jan 4, 2016, and July 31, 2016, so as to quantify the post-surgical burden of SSI all over of the world. In all, 12,539 patients from 343 hospitals in 66 countries participated in the study. Of these, 58.5% were from high human development index (HDI) countries, 31.2% were from middle HDI countries, and 10.2% of patients were from low-HDI countries.
The results revealed that 12.3% of patients suffered a SSI within 30 days of surgery. The incidence of SSI varied between countries; while those with a high HDI had a 9.4% of incidence of SSI, middle-income countries showed a 14% incidence rate, while those with low income experienced a 23.2% of SSI. The highest SSI incidence in each HDI group was after dirty surgery, with 17.8% in high-HDI countries; 31.4% in middle-HDI countries; and 39.8% in low-HDI countries. Following adjustment, patients in low-HDI countries were at greatest risk of SSI, with 21.6% of SSI patients developing an infection resistant to the prophylactic antibiotic used. The study was published on February 13, 2018, in Lancet Infectious Diseases.
“The incidence of SSI remained higher in low-HDI countries than in middle-HDI or high-HDI countries, despite adjustment for factors describing patients, diseases (including contamination), procedures, safety, and hospitals,” concluded senior author Ewen Harrison, MD, of the University of Edinburgh, and colleagues. “Length of hospital stay was three times longer for patients affected by SSI than for patients with no SSI. Delayed return to work or school carries a societal burden, which is likely to be greater in lower middle income countries.”
SSI is the most common postoperative complication, occurring in approximately 2-5% of patients who undergo clean extra-abdominal surgeries, such as thoracic and orthopedic surgery, and in up to 20% of patients who undergo intra-abdominal surgery interventions. Besides the pain and suffering to patients, it could lead to catastrophic health expenditure and impoverishment to those patients who are required to pay for their own treatment, and a significant financial burden on healthcare providers.
Related Links:
University of Edinburgh
University of Warwick
Latest Critical Care News
- Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
- Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
- Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
- Generative AI Technology Detects Heart Disease Earlier Than Conventional Methods
- Wearable Technology Predicts Cardiovascular Risk by Continuously Monitoring Heart Rate Recovery
- Wearable Health Monitoring Device Measures Gases Emitted from and Absorbed by Skin
- Groundbreaking Technology Rapidly Detects Airborne Influenza Viruses
- Handheld Device Could Transform Heart Disease Screening
- Flexible Semi-Autonomous Robot Could Deliver Medicine Inside Body
- Neurorestorative Treatment Strategies Hold Promise for Most Severe Forms of Epilepsy
- Gene Discovery Could Help Grow New Heart Arteries
- Study Discovers Invisible Transmission of Common Hospital-Associated Infection
- Non-Invasive Neuro-Ophthalmology Techniques Could Detect Brain Tumors Earlier
- Mass Manufactured Nanoparticles to Deliver Cancer Drugs Directly to Tumors
- World’s Smallest Pacemaker Fits Inside Syringe Tip
- AI-Powered, Internet-Connected Medical Devices to Revolutionize Healthcare, Finds Study
Channels
Surgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more